Funding for this research was provided by:
U.S. Department of Veterans Affairs (BX-003478)
Received: 19 August 2020
Accepted: 3 November 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: This study was approved through the Duke University institutional review board (Duke IRB Protocol Pro00046651).
: Not applicable.
: TM reports grants from Bayer HealthCare that funded the submitted work. VT reports grants and personal fees from Actelion, grants from Arena, grants and personal fees from Bayer, grants from Reata, grants and personal fees from United Therapeutics, and personal fees from VWave all outside the submitted work. ACS, HZ, YL, AP, ZK, EG, KK, BEF, TF, SNM, KP have no disclosures.